ZFIN ID: ZDB-PERS-170627-7
Melong, Nicole
Email: nmelong@gmail.com
URL:
Affiliation: Berman Lab
Address: CHEO RI 401 Smyth Road Ottawa, ON K1H 8L1
Country: Canada
Phone:
Fax:
ORCID ID:


BIOGRAPHY AND RESEARCH INTERESTS


PUBLICATIONS
Pietrobon, A., Yockell-Lelièvre, J., Melong, N., Smith, L.J., Delaney, S.P., Azzam, N., Xue, C., Merwin, N., Lian, E., Camacho-Magallanes, A., Doré, C., Musso, G., Julian, L.M., Kristof, A.S., Tam, R.Y., Berman, J.N., Shoichet, M.S., Stanford, W.L. (2023) Tissue-Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 10(26):e2302611
Piccolo, O., Lincoln, J.D., Melong, N., Orr, B.C., Fernandez, N.R., Borsavage, J., Berman, J.N., Robar, J., Ha, M.N. (2022) Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type analysis. Scientific Reports. 12:1559
Wertman, J.N., Melong, N., Stoyek, M.R., Piccolo, O., Langley, S., Orr, B., Steele, S.L., Razaghi, B., Berman, J.N. (2020) The identification of dual protective agents against cisplatin-induced oto-and nephrotoxicity using the zebrafish model. eLIFE. 9:
Pringle, E.S., Wertman, J., Melong, N., Coombs, A.J., Young, A.L., O'Leary, D., Veinotte, C., Robinson, C.A., Ha, M.N., Dellaire, G., Druley, T.E., McCormick, C., Berman, J.N. (2019) The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases. Viruses. 12(1):
Arumuggam, N., Melong, N., Too, C.K., Berman, J.N., Rupasinghe, H.V. (2017) Phloridzin docosahexaenoate, a novel flavonoid derivative, suppresses growth and induces apoptosis in T-cell acute lymphoblastic leukemia cells. American journal of cancer research. 7:2452-2464
Leung, A.W.Y., Veinotte, C.J., Melong, N., Oh, M.H., Chen, K.T.J., Enfield, K., Backstrom, I., Warburton, C., Yapp, D.T., Berman, J.N., Bally, M.B., Lockwood, W.W. (2017) In Vivo Validation of PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target.. Clinical cancer research : an official journal of the American Association for Cancer Research. 23(21):6555-6566
Melong, N., Steele, S., MacDonald, M., Holly, A., Collins, C.C., Zoubeidi, A., Berman, J.N., Dellaire, G. (2017) Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia. Scientific Reports. 7(1):14698

NON-ZEBRAFISH PUBLICATIONS